99mTc-MIRC208 SPECT/CT Imaging for HER2-Positive Cancer Patients
Clinical trial NCT04591652 · UNKNOWN
Trial details
- NCT number
- NCT04591652
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2024-08-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.